|
|
Psilocybin As Effective As Escitalopram At Reducing Depression
May 7, 2021
 |
Several studies have reported that psilocybin has antidepressant properties, however direct comparisons between established depression treatments and psilocybin are lacking. In a phase 2, double-blind randomized controlled trial included patients with long-term, moderate-to-severe major depressive disorder, over a six-week period. Patients were randomly... |
|
 Continue reading (Members only)
|
|
Mood Disorder Patients Experience Seasonal Changes In Varying Degrees
April 22, 2021
 |
Seasonal affective disorder is defined as depression that occurs with seasonality -typically occurring in the autumn and winter months and remitting in spring and summer. It is thought to be pathophysiologically related to circadian misalignment and can often be effectively treated, or even prevented, with light therapy and/or bupropion. Given that... |
|
Continue reading
|
|
Guidelines For The Use Of Ketamine For Treatment-Resistant Depression
April 12, 2021
 |
An international expert opinion on the use of ketamine for treatment-resistant depression was recently published. Although the various formulations of ketamine have not been compared directly in randomized controlled trials, intranasal esketamine and intravenous ketamine have the strongest evidence of short-term efficacy and safety in patients with .. |
|
Continue reading
|
|
|
|
PsychopharmaStahlogy Show: Psychedelic Assisted Psychotherapy
March 30, 2021
 |
The PsychopharmaStahlogy Show is a special podcast series released on the NEI Podcast. In the first three part series, Dr. Andrew Cutler asks Dr. Stephen Stahl important questions relating to psychedelic assisted psychotherapy as a novel approach to the treatment of psychiatric disorders... |
|
Continue reading
|
|
|
|
|
|
|
|
|
|